OR WAIT null SECS
August 08, 2024
A holistic approach to automation can provide benefits at all stages of development and manufacturing.
May 30, 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.
September 29, 2023
Twin-screw granulation process insight is growing as researchers employ new analytical technologies and investigate new ways to use the equipment.
September 28, 2023
Sustainability advances are being made, but more investment is needed.
August 22, 2023
The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.
June 14, 2023
The new excipients manufacturing facility is expected to be completed in 2025.
November 03, 2022
The state of oral solid dose manufacturing is influenced by new approaches, novel technologies, and the structural evolution of the raw materials market.
July 03, 2022
Lack of toxicity data and poor physicochemical properties must be overcome.
May 03, 2022
Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions.